Uma Sinha, Chief Scientific Officer at Eidos Therapeutics, Inc. (EIDX), sold 7,967 shares at $35.65 ($286K) on 2019-07-25, disclosed to the SEC on 2019-07-29.
Open-market sale of $286k EIDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.65 | 2,967 | $106K | 36.9% |
| 2 | $35.65 | 2,967 | $106K | 36.9% |
| 3 | $36.53 | 1,300 | $47K | 16.6% |
| 4 | $37.31 | 700 | $26K | 9.1% |
| 5 | $38.35 | 33 | $1K | 0.4% |
| Total | $35.95 avg | 7,967 |
| $286K |
| 100% |
| Filing → |
| EIDX | SELL | 2020-10-30 | $456K | — | Filing → |
| EIDX | SELL | 2020-10-02 | $515K | — | Filing → |
| EIDX | SELL | 2019-12-20 | $1.5M | — | Filing → |